Medicus Pharma (MDCX) Share-based Compensation (2024 - 2025)
Medicus Pharma (MDCX) posted Share-based Compensation of $429712.0 for Q4 2025, down 49.61% quarter-over-quarter from $852757.0 in Q3 2025, and up 368.48% year-on-year from $91724.0 in Q4 2024.
Medicus Pharma (MDCX) Share-based Compensation (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has reported Share-based Compensation for 2 consecutive years, with $429712.0 the latest figure, recorded in Q4 2025.
- Share-based Compensation for Q4 2025 came in at $429712.0, up 368.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (up 112.05% YoY), and the FY2025 annual result was $1.5 million, up 112.05% from the prior year.
- Share-based Compensation was $429712.0 for Q4 2025 at Medicus Pharma, down from $852757.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $852757.0 in Q3 2025 and troughed at $35953.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 161.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 300.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 444.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 185.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 218.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 272.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Medicus Pharma | 6.91 Mn | -1.69 Mn | - | 429,712.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 429,712.00 |
| Dec 31, 2025 | 429,712.00 |
| Sep 30, 2025 | 852,757.00 |
| Sep 30, 2025 | 852,757.00 |
| Jun 30, 2025 | 117,448.00 |
| Jun 30, 2025 | 117,448.00 |
| Mar 31, 2025 | 112,277.00 |
| Mar 31, 2025 | 112,277.00 |
| Dec 31, 2024 | 91,724.00 |
| Dec 31, 2024 | 91,724.00 |
| Jun 30, 2024 | 585,442.00 |
| Jun 30, 2024 | 585,442.00 |
| Mar 31, 2024 | 35,953.00 |
| Mar 31, 2024 | 35,953.00 |